Hospital
Kemper Cah, INC.
Kemper Cah, INC. was paid $4.06M by Medicaid between Jan 2018 and Dec 2024, across 65 billing codes. Its largest line is 99284, emergency room visit (serious) — 17% of everything it billed.
33Billing provider infoKEMPER CAH, INC.
DE KALB, MS 39328
DE KALB, MS 39328
33aNPI1679875645assigned 11/24/2010
33bProvider typeCritical Access Hospital
28Total paid$4.06M
24GClaims110,240
24DCodes billed65
24AFirst – last monthJan 2018 – Dec 2024
Compared with peers
Next to other Critical Access Hospital providers in Mississippi
Rank by total paid#16 of 32
Median peer was paid$3.94M
This provider vs. median1.0×
Peers share this provider's primary NPPES type and state. Size alone says nothing about billing quality: a big agency or a hospital system is expected to sit far above the median.
Auditor's notes
Automated statistical signals. Not evidence of fraud — how these are computed.
Entity ProliferationAuthorized official KENNEDY, DON controls 20+ related entities in our dataset. Read more
Box 24A · Dates of service
Paid by month
Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider
By year, as a table
| Year | Claims | Paid | |
|---|---|---|---|
| 2018 | 15,128 | $538K | |
| 2019 | 12,661 | $442K | |
| 2020 | 8,087 | $275K | |
| 2021 | 12,979 | $510K | |
| 2022 | 21,227 | $727K | |
| 2023 | 23,348 | $840K | |
| 2024incomplete | 16,810 | $732K |
Box 24 · Service lines
What it billed for
| Code | Service | Share | Claims | Bene. records | Paid |
|---|---|---|---|---|---|
| 99284 | Emergency room visit (serious)Emergency department visit for the evaluation and management, high severity | 17% | 4,337 | 3,229 | $671K |
| 99283 | Emergency room visit (moderate)Emergency department visit for the evaluation and management, moderate severity | 16% | 4,991 | 4,009 | $666K |
| 87428 | 11% | 7,789 | 6,721 | $428K | |
| 99285 | Emergency room visit (most serious)Emergency department visit for the evaluation and management, high severity with immediate threat to life | 7.4% | 1,737 | 1,201 | $303K |
| 87426 | Infectious agent antigen detection, SARS-CoV-2 (COVID-19) | 6.1% | 7,904 | 6,585 | $250K |
| 87804 | Infectious agent antigen detection by immunoassay; Influenza, each type | 5.4% | 13,664 | 7,290 | $220K |
| 87880 | Infectious agent antigen detection by immunoassay; Streptococcus, group A | 5.1% | 15,484 | 13,278 | $206K |
| 99282 | Emergency department visit for the evaluation and management, low to moderate severity | 4.9% | 2,310 | 1,949 | $200K |
| 96372 | Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular | 3.9% | 3,359 | 2,739 | $160K |
| 71046 | Radiologic examination, chest; 2 views | 3.5% | 3,626 | 3,115 | $144K |
| 87502 | Infectious agent detection by nucleic acid, influenza virus, for multiple types or subtypes, includes all targets | 3.3% | 1,673 | 1,585 | $134K |
| 87635 | Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe | 2.7% | 2,664 | 2,468 | $110K |
53 more codes
| 74018 | 2.0% | 1,921 | $79K | |
| 96374 | Therapeutic, prophylactic, or diagnostic injection; intravenous push, single or initial substance | 1.8% | 811 | $75K |
| 87651 | Infectious agent detection by nucleic acid; Streptococcus, group A, amplified probe | 1.3% | 1,800 | $54K |
| 90853 | Group psychotherapy (other than of a multiple-family group) | <1% | 418 | $40K |
| 93005 | Electrocardiogram, routine ECG with at least 12 leads; tracing only, without interpretation and report | <1% | 1,796 | $37K |
| 99281 | Emergency department visit for the evaluation and management, self-limited or minor | <1% | 742 | $31K |
| 71045 | Radiologic examination, chest; single view | <1% | 884 | $29K |
| 85025 | Blood count; complete (CBC), automated, and automated differential WBC count | <1% | 5,090 | $27K |
| 80053 | Comprehensive metabolic panel | <1% | 3,264 | $21K |
| 70450 | Computed tomography, head or brain; without contrast material | <1% | 227 | $19K |
| 97110 | Therapeutic procedure, each 15 minutes; therapeutic exercises to develop strength and endurance, flexibility and range of motion | <1% | 416 | $16K |
| 96365 | Intravenous infusion, for therapy, prophylaxis, or diagnosis; initial, up to 1 hour | <1% | 149 | $15K |
| 73560 | <1% | 335 | $13K | |
| 96375 | Therapeutic injection; each additional sequential IV push | <1% | 387 | $12K |
| 81025 | <1% | 1,790 | $12K | |
| 96361 | Intravenous infusion, hydration; each additional hour | <1% | 396 | $11K |
| 94640 | Pressurized or nonpressurized inhalation treatment for acute airway obstruction | <1% | 104 | $11K |
| 81003 | <1% | 3,849 | $8K | |
| 81001 | <1% | 3,153 | $8K | |
| 80048 | Basic metabolic panel (calcium, ionized) | <1% | 931 | $8K |
| 80305 | <1% | 700 | $7K | |
| 36415 | Collection of venous blood by venipuncture | <1% | 3,715 | $6K |
| 87634 | <1% | 78 | $5K | |
| 84484 | <1% | 727 | $4K | |
| 72100 | <1% | 85 | $4K | |
| 87807 | <1% | 362 | $4K | |
| 73630 | <1% | 81 | $3K | |
| 87210 | <1% | 765 | $3K | |
| 73610 | <1% | 95 | $3K | |
| J0561 | Injection, penicillin g benzathine, 100,000 units | <1% | 14 | $2K |
| 73030 | <1% | 41 | $1K | |
| 74176 | Computed tomography, abdomen and pelvis; without contrast material | <1% | 14 | $1K |
| 82553 | <1% | 86 | $855.11 | |
| 83735 | <1% | 250 | $829.13 | |
| 73130 | <1% | 12 | $701.57 | |
| 82150 | <1% | 106 | $637.43 | |
| 83874 | <1% | 47 | $500.84 | |
| J1885 | Injection, ketorolac tromethamine, per 15 mg | <1% | 994 | $419.48 |
| 83880 | <1% | 14 | $418.06 | |
| Q3014 | Telehealth originating site facility fee | <1% | 19 | $296.30 |
| 87086 | Culture, bacterial; quantitative colony count, urine | <1% | 81 | $294.94 |
| 83690 | <1% | 39 | $253.31 | |
| 87088 | <1% | 28 | $227.75 | |
| J0696 | Injection, ceftriaxone sodium, per 250 mg | <1% | 742 | $174.06 |
| 82962 | <1% | 112 | $168.93 | |
| 85610 | <1% | 46 | $148.25 | |
| 83036 | Hemoglobin; glycosylated (A1C) | <1% | 19 | $144.46 |
| J1100 | Injection, dexamethasone sodium phosphate, 1 mg | <1% | 430 | $101.47 |
| J2405 | Injection, ondansetron hydrochloride, per 1 mg | <1% | 357 | $8.70 |
| J8499 | Prescription drug, oral, non chemotherapeutic, nos | 0% | 1,019 | $0.00 |
| J7030 | Infusion, normal saline solution , 1000 cc | 0% | 28 | $0.00 |
| J3490 | Unclassified drugs | 0% | 1,100 | $0.00 |
| J2360 | Injection, orphenadrine citrate, up to 60 mg | 0% | 33 | $0.00 |
Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.
From NPPES
Who's on the registration
Authorized officialKENNEDY, DON (REGIONAL CEO)
| Provider | Location | Paid |
|---|---|---|
| Rush Medical Foundation | Meridian, MS | $29.41M |
| Laird Hospital, INC. | Union, MS | $7.23M |
| Laird Hospital, INC. | Meridian, MS | $5.90M |
| Laird Hospital, INC | Meridian, MS | $5.27M |
| Rush Medical Foundation | Quitman, MS | $4.69M |
| Kemper, Cah, INC | Livingston, AL | $4.50M |
| Medical Foundation, INC. | Meridian, MS | $4.20M |
| Scott Regional Medical Center, INC. | Morton, MS | $3.77M |
| Kemper Cah, INC | Meridian, MS | $3.39M |
| Rush Hospital/Butler, INC | Butler, AL | $1.94M |
| Medical Foundation, INC. | Meridian, MS | $1.82M |
| The Medical Store, INC. | Meridian, MS | $1.66M |
| Rush Medical Foundation | Meridian, MS | $1.61M |
| Medical Foundation, INC. | Meridian, MS | $1.37M |
| Laird Hospital, INC. | Union, MS | $1.31M |
| Medical Foundation, INC. | Meridian, MS | $1.27M |
| Scott Regional Medical Center, INC. | Morton, MS | $1.21M |
| Rush Medical Foundation | Quitman, MS | $978K |
| Kemper Cah, INC | Meridian, MS | $910K |
| Laird Hospital, INC. | Philadelphia, MS | $898K |
Matched on the authorized-official name exactly as entered in NPPES. A common name can match unrelated people.